Three experts recently gathered to discuss how ATMP developers weathered the pandemic and the potential implications on quality control.
Parkinson’s Disease. Diabetes. Muscular dystrophy. These diseases all lack cures, but they also share another important similarity: the quest for their cures is playing out in the field of ATMPs.